Epilepsy trials recruiting in Pennsylvania

All Epilepsy trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
  NCT07019922 · Phase: Phase 3 · Ages: 1 Day to 18 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy
  NCT07227857 · Phase: Phase 1, Phase 2 · Ages: 2 Years to 12 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
  NCT07219407 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
  NCT04462770 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
  NCT06132893 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
  NCT05667142 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
  NCT06063850 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
  NCT05066217 · Phase: Phase 3 · Ages: 2 Years to 55 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Diagnosing Epilepsy To EffeCT Change
  NCT07110337 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
  NCT07110454 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Epilepsy Learning Healthcare System (ELHS)
  NCT06265103 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Pennsylvania: Hershey, Philadelphia
• Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
  NCT05219617 · Phase: Phase 3 · Ages: 4 Years to 55 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Localizing Epileptic Networks Using MRI and iEEG
  NCT04649008 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
  NCT01694940 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Pennsylvania: Philadelphia, Pittsburgh
• Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
  NCT01238250 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Pennsylvania: Lewisburg
• Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
  NCT05450978 · Phase: Not specified · Ages: 18 Years to 45 Years · Sex: Female · Pennsylvania: Pittsburgh
• Prospective Natural History Study of POLG Disease
  NCT07775872 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Pennsylvania: Philadelphia
• STXBP1 and SYNGAP1 Related Disorders Natural History Study
  NCT06555965 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Pennsylvania: Philadelphia
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
  NCT07563881 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
  NCT05135091 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Pennsylvania: Philadelphia
• Subcortical Arousal in Perceptual Awareness
  NCT06934356 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years and older · Sex: All (male and female) · Pennsylvania: Pittsburgh